Delivery Order SPE2DB20D1110-SPE2DB24FK56H

Award Date 9/25/24
Potential Completion Date 9/26/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,599.65, is a delivery order for the medical product "ZAFEMY 150-35 MCG/DAY PATCH 3S". The contract has a firm fixed price pricing type and an ultimate completion date of March 12, 2025. Amerisourcebergen is the prime contractor and holds a significant Indefinite Delivery Contract (IDC)...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product (ZAFEMY 150-35 MCG/DAY PATCH 3S) with a ceiling value of $8,383.26. This order was issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp that has a potential value of up to $999,999,999.00 and runs through...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,562.91, is for the delivery of the pharmaceutical product "ZAFEMY 150-35 MCG/DAY PATCH 3S". The award has an ultimate completion date of April 29, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not designated as a set-aside. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,774.02 firm-fixed-price delivery order is for the supply of ZAFEMY 150-35 MCG/DAY PATCH 3S, a medication, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,613.37, is a Firm Fixed Price Delivery Order for the medical product "ZAFEMY 150-35 MCG/DAY PATCH 3S". The contract has an ultimate completion date of January 6, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,109.72, is for the delivery of ZAFEMY 150-35 MCG/DAY PATCH 3S medical supplies. The contract has a firm fixed price pricing type and an ultimate completion date of January 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,556.00, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the pharmaceutical product "ZAFEMY 150-35 MCG/DAY PATCH 3S" and has a firm fixed price structure with an ultimate completion date of January 31, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for...
This federal contract award, valued at $3,396.27, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,454.84, is for the delivery of the pharmaceutical product "ZAFEMY 150-35 MCG/DAY PATCH 3S". The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 24, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $2,302.31, is for the delivery of 4565110661 ! ZAFEMY 150-35 MCG/DAY PATCH 3S, a specialty pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB20D1110
    Indefinite Delivery Contract
  • SPE2DB20D1110-SPE2DB24FK56H
    Delivery Order

This contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,993.13 firm-fixed-price delivery order is for the supply of the drug product ZAFEMY 150-35 MCG/DAY PATCH 3S, with a period of performance through September 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which provides a broad range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/25/24, 9:19 AM